InvestWiserSpectraCure AB
SPEC · Nasdaq Stockholm · Healthcare
0.02SEK
+1.1%last day
Price as of 2 October 2026
Performance
1 month
−23.8%
1 year
−91.1%
3 years, per year
−83.1%
5 years, per year
−71.4%
Largest fall, 3 years
−99.7%
Below the peak now
−100.0%
Volatility, 1 year
116.4%
Return with dividends reinvested.
Key figures
P/E
negative earnings
P/B
0.2
Dividend yield
0.0%
Return on equity
−59.3%
Net margin
–
Market value
2 m USD
Quality, value and trend
Where SpectraCure stands against every Nordic stock today. 100 is best.
60
Profitability and a sound balance sheet over time. Better than 60% of Nordic stocks.
56
The price measured against earnings, assets and cash flow. Better than 56% of Nordic stocks.
1
The price development over the past year. Better than 1% of Nordic stocks.
27
Quality, value and trend together. Better than 27% of Nordic stocks.
About SpectraCure
SpectraCure AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 13 employees.
SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical fibers; and disposable items comprising needles, optical fibers, and light-sensitive medication. The company was incorporated in 2003 and is based in Lund, Sweden.
See the full analysis in InvestWiser.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
See the full analysis